MOTCO’s Vertex Pharmaceuticals VRTX Stock Holding History

MOTCO’s Portfolio VRTX Stock Details VRTX Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	$9.44K	Buy	19 +5	+36%	+$2.22K	﹤0.01%	440
2026 Q1	$6.25K	Hold	14	–	–	﹤0.01%	491
2025 Q4	$6.35K	Hold	14	–	–	﹤0.01%	507
2025 Q3	$5.48K	Sell	14 -14	-50%	-$5.85K	﹤0.01%	518
2025 Q2	$12.8K	Sell	28 -101	-78%	-$46.5K	﹤0.01%	412
2025 Q1	$62.5K	Sell	129 -2	-2%	-$932	0.01%	271
2024 Q4	$52.8K	Hold	131	–	–	0.01%	276
2024 Q3	$60.9K	Buy	131 +117	+836%	+$56.2K	0.01%	308
2024 Q2	$6.56K	Hold	14	–	–	﹤0.01%	580
2024 Q1	$5.85K	Sell	14 -15	-52%	-$6.34K	﹤0.01%	547
2023 Q4	$11.8K	Hold	29	–	–	﹤0.01%	477
2023 Q3	$10.1K	Hold	29	–	–	﹤0.01%	504
2023 Q2	$10.2K	Buy	29 +15	+107%	+$5.05K	﹤0.01%	504
2023 Q1	$4.41K	Hold	14	–	–	﹤0.01%	508
2022 Q4	$4.04K	Sell	14 -370	-96%	-$113K	﹤0.01%	523
2022 Q3	$111K	Buy	+384	New	+$110K	0.01%	276
2021 Q1	–	Sell	-16	Closed	-$4K	–	801
2020 Q4	$4K	Hold	16	–	–	﹤0.01%	622
2020 Q3	$4K	Hold	16	–	–	﹤0.01%	539
2020 Q2	$5K	Hold	16	–	–	﹤0.01%	487
2020 Q1	$4K	Buy	+16	New	+$3.67K	﹤0.01%	506
2019 Q4	–	Sell	-24	Closed	-$4K	–	556
2019 Q3	$4K	Sell	24 -218	-90%	-$38.6K	﹤0.01%	466
2019 Q2	$44K	Buy	+242	New	+$42.3K	﹤0.01%	378
2019 Q1	–	Sell	-1	Closed	–	–	571
2018 Q4	$0	Buy	+1	New	+$173	﹤0.01%	600

Other funds holding VRTX

Capital World Investors Los Angeles, California $846B AUM 46.74% 1-Year Est. Return

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Capital Research Global Investors Los Angeles, California $717B AUM 35.42% 1-Year Est. Return

Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM

State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

Invesco Atlanta, Georgia $1.26T AUM 61.52% 1-Year Est. Return

JP Morgan Chase New York $1.81T AUM 41.13% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM

Capital International Investors Los Angeles, California $484B AUM 34.9% 1-Year Est. Return

MOTCO's VRTX Position: Q2 2026 in Review

MOTCO increased its Vertex Pharmaceuticals (VRTX) stake by 36% in Q2 2026, buying an estimated $2.22K and bringing the position to 19 shares worth $9.44K. The position accounts for ﹤0.01% of the portfolio, ranked #440.

MOTCO first reported a position in VRTX in Q4 2018 and has held it in 23 quarters since. The position peaked at $111K in Q3 2022. 1,747 funds tracked by Wall St. Rank hold VRTX as of Q2 2026.

MOTCO held 19 shares of Vertex Pharmaceuticals worth $9.44K as of Q2 2026.
MOTCO bought 5 Vertex Pharmaceuticals shares in Q2 2026, an estimated $2.22K.
Vertex Pharmaceuticals made up ﹤0.01% of MOTCO's portfolio in Q2 2026, its #440 holding.
MOTCO first reported a position in Vertex Pharmaceuticals in Q4 2018 and has held it in 23 quarters since.
MOTCO's Vertex Pharmaceuticals position peaked at $111K in Q3 2022.
1,747 funds tracked by Wall St. Rank held Vertex Pharmaceuticals as of Q2 2026.

Based on MOTCO's 13F filing for Q2 2026, filed 31 Jul 2026.